Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHD

Recently developed cell-based therapies have shown potential for graft-versus-host disease (GvHD) mitigation. Our team previously developed a protocol to generate human monocyte-derived suppressor Cells (HuMoSC), a subpopulation of CD33+ suppressor cells of monocytic origin. CD33+HuMoSC successfully...

Descripción completa

Detalles Bibliográficos
Autores principales: Gérard, Claire, Thébault, Marine, Lamarthée, Baptiste, Genet, Coraline, Cattin, Florine, Brazdova, Andréa, Janikashvili, Nona, Cladière, Claudie, Ciudad, Marion, Ouandji, Séthi, Ghesquière, Thibault, Greigert, Hélène, Tinel, Claire, Adotevi, Olivier, Saas, Philippe, Samson, Maxime, Audia, Sylvain, Bonnotte, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957111/
https://www.ncbi.nlm.nih.gov/pubmed/35345675
http://dx.doi.org/10.3389/fimmu.2022.827712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957111/
https://www.ncbi.nlm.nih.gov/pubmed/35345675
http://dx.doi.org/10.3389/fimmu.2022.827712

Ejemplares similares